首页> 外文期刊>FEBS Letters >Ca2+ channel agonist BAY‐k 8644 does not elicit Ca2+ release from skeletal muscle sarcoplasmic reticulum
【24h】

Ca2+ channel agonist BAY‐k 8644 does not elicit Ca2+ release from skeletal muscle sarcoplasmic reticulum

机译:Ca2 +通道激动剂BAY-k 8644不会引起骨骼肌肌浆网释放Ca2 +

获取原文
           

摘要

>BAY-k 8644, a nifedipine analogue, promotes Ca2+ influx into excitable cells via plasma membrane voltage-sensitive Ca2+ channels. We report here that sarcoplasmic reticulum (SR) Ca2+ release channels are insensitive to BAY-k 8644, as studied in highly purified isolated fractions and in chemically skinned fibers of rabbit skeletal muscle. This result suggests that a subcellular heterogeneity exists among Ca2+ channels, at least with respect to drug-receptor sites. In the course of this study, however we found that BAY-k 8644 reversibly inhibits the SR Ca2+ pump, i.e., it decreases Ca2+ influx into the SR lumen, although at concentrations (IC50 = 3-5 × 10−5M) much higher than those effective on voltage-sensitive Ca2+ channels.
机译:硝苯地平类似物> BAY-k 8644通过细胞膜电压敏感的Ca 2 + 通道促进Ca 2 + 流入可兴奋细胞。我们在这里报告,肌浆网(SR)Ca 2 + 释放通道对BAY-k 8644不敏感,这是在高度纯化的分离级分和兔骨骼肌化学皮肤纤维中研究的。这一结果表明,至少在药物受体位点上,Ca 2 + 通道之间存在亚细胞异质性。然而,在本研究过程中,我们发现BAY-k 8644可逆地抑制SR Ca 2 + 泵,即,它减少了Ca 2 + 流入SR管腔的流量。 ,尽管其浓度(IC 50 = 3-5×10 −5 M)远高于对电压敏感的Ca 2 + 有效的浓度渠道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号